— Know what they know.
Not Investment Advice

TIL NASDAQ

Instil Bio, Inc.
1W: +0.7% 1M: -6.1% 3M: -6.5% YTD: -35.9% 1Y: -62.2% 3Y: -12.4% 5Y: -98.4%
$7.22
-0.01 (-0.21%)
 
Weekly Expected Move ±3.8%
$7 $7 $7 $7 $8
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 30 · $49.0M mcap · 4M float · 0.368% daily turnover · Short 52% of daily vol

Supply Chain Overview

3 relationships
3
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2024-08-01
Earliest Filing
2025-03-31
Latest Filing
partner: 3

Counterparties (Filed by TIL)

3 relationships

Companies named in TIL's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
Jefferies LLC JEF partner Sales agent for the Company's open market sale of common stock 2025-03-31 View
SynBioTx, Inc. SYIN partner Wholly-owned subsidiary of Instil Bio, Inc. that entered into a license and collaboration agreement with ImmuneOnco. 2024-08-01 View
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. — partner Granted SynBioTx an exclusive license to research, develop, manufacture and commercialize certain antibodies outside of 2024-08-01 View
Recent 8-K Filings (20)
Filing Date Description Type SEC
2026-08-13 Earnings Release; Exhibits View
2026-06-11 Shareholder Vote View
2026-05-15 Earnings Release; Exhibits View
2026-04-03 Accountant Change; Exhibits View
2026-03-27 Earnings Release; Exhibits View
2026-01-06 Termination of Material Definitive Agreement View
2025-11-13 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-08-13 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-07-31 Other Events View
2025-05-28 Submission of Matters to a Vote of Security Holders View
2025-05-27 Regulation FD Disclosure; Other Events; Financial Statements and Exhibits View
2025-05-22 Regulation FD Disclosure; Financial Statements and Exhibits View
2025-05-13 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-03-31 Entry into Material Definitive Agreement; Financial Statements and Exhibits Agreement View
2025-03-04 Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex View
2025-01-14 Other Events; Financial Statements and Exhibits View
2024-12-23 Entry into Material Definitive Agreement; Termination of Material Definitive Agreement; Creation of Agreement View
2024-11-13 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2024-09-16 Regulation FD Disclosure; Other Events; Financial Statements and Exhibits View
2024-09-06 Costs Associated with Exit or Disposal Activities View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms